Friday, June 12, 2026

At BIO, the French delegation underlines its healthcare and biotechnology development plans


exist biology convention San Diego June 13-16France will send a delegation 87 Biotechnology and Medical Technology The company has activities on every day of the conference.The French delegation also brought a message about the country’s efforts to nurture innovative Healthcare ecosystem, especially when it comes to entrepreneurship.It also plans to further invest in building and developing healthcare and life sciencess company, with the aim of supporting the country to become a European leader in these fields.

France has a strong partnership with the U.S. Last year, France attracted less than a quarter of U.S. investment in Europe, compared with 20% for U.K. More than 4,400 U.S. companies have subsidiaries in France, According to data from the French Business Report Regarding foreign investment in France.

The French healthcare startup ecosystem is home to 2,000 companies, including 750 biotech companies. These businesses provide more than 10,000 jobs – 79% of which added staff last year. This year, it plans to recruit another 2,000 people, mainly engaged in R&D and production. France is the leading country for R&D activity in Europe. The number of R&D projects continued to grow significantly.

Healthcare investment soars in 2021 – French healthcare and life sciences startups raise $2.46bn (€2.3bn), 50% increase from 2020.

Franck Mouton, president of France Biotech, attributed the growth to public policies supporting innovation in healthcare, the progressive structure of the industry, and the impact of Covid-19 in increasing awareness and interest in the healthcare and biotech industries.

“France now has access to a wide range of assets designed to ensure that patients are treated as quickly as possible and to apply these successes internationally,” Mouton said.

In 2021, French President Emmanuel Macron unveiled an $8 billion (7.5 billion euro) “Healthcare Innovation Plan”. The overall aim is to make France a leading innovative and sovereign European country in healthcare through the development of biotherapeutics and support for start-ups, particularly in the areas of biomedical research, clinical trials and, more generally, breakthrough innovations in health care field for “more predictive, preventive and innovative medicines”.

Here are some of the companies that will be participating Convention:

Affilogica biotechnology company focused on drug discovery and development in immunology and oncology through early-stage collaborations with global industry leaders in the pharmaceutical industry. touch: Nadège Prel

Matt Pharma With groundbreaking and innovative therapeutic approaches based on gut microbiome modulation. touch: Savita Bernal

Netris Pharmaceuticals New treatment options are being developed for cancer patients.It is currently undergoing a Phase 2 clinical trial in more than 240 patients in combination with chemotherapy and Pembrolizumab (Keytruda). touch: Christopher Guichard

Phost’in Therapeutics A new class of highly potent cancer-fighting chemical entities targeting the key N-glycosylation machinery responsible for suppressing immune responses is being developed. touch: Karin Squirt

Varneva, a specialty vaccine company focused on the development and commercialization of preventive vaccines for infectious diseases with significant unmet medical need. The company has been in the spotlight over the past 2 years for its inactivated vaccine candidate against Covid-19. touch: Damian Decis

In addition, the French delegation will host several events at the BIO conference. Here are some activities to add to your schedule:

« Driving global innovation in biotechnology: a high-level discussion» roundtable: This public meeting, chaired by Jannie Oosthuizen (President of Merck & Co.), will gather input from countries including France, and will be represented by Philippe Etienne, French Ambassador to the United States.

when: Monday, June 13, 12:50pm

Where: conference Center

French reception: The opening ceremony will be chaired by Philippe Etienne, the French ambassador to the United States. This was followed by presentations from innovative biotech companies including Netri, Vaxxel and Novadiscovery.

when: Monday, June 13, 4:30 pm

Where: French Healthcare Pavilion, booth #2922

Global Innovation Center will host french healthcare organize as they present French ecosystem.

when: Tuesday, June 14, 2:30 pm

Where: Global Innovation Center – Company Showroom

French Medical Yacht Party: There will be an introduction by Julie Duhaut-Bedos, Consul General of France in Los Angeles, networking, buffet, refreshments and a DJ set.

when: Tuesday, June 14, 5:30 pm

Where: Spirit of San Diego Yachting, 990 North Harbour Drive (the yacht will remain docked) registration, Click here.

audience: 270+ European and North American healthcare stakeholders

To see the full list of French speakers click here.

The French delegation will also meet Santiago-based organizations and Brazilian actors at a four-day themed breakfast.

To learn more about the French healthcare and biotech industry and its presence at BIO, Click here.

photo: Pixtum, Getty Images



Source link

Related articles

spot_imgspot_img